Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Microbiol ; 62(1): 55-63, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20509029

RESUMO

Quorum sensing (QS) enables microorganisms to monitor their own density of population, and also their pathogenicity by intracellular signals, and synchronizing their specialized gene system in a particular cell density. QS system has been shown in Candida sp. as switching mechanism between successive phases in Candida cell morphology. The lag phase that occurs due to QS is commonly attributed to auto-stimulatory compounds, such as farnesol and farnesoic acid, which are released in the medium. The aim of this manuscript is to demonstrate the involvement of 3(R)-HTDE, a metabolite of linoleic acid, in the QS mechanism of Candida albicans. We show that 3(R)-HTDE, a ß-oxidation metabolite of endogenously present linoleic acid, accelerates cell morphogenesis in C. albicans, with alteration of gene expressions necessary for hyphal formation at right density of population utilizing aerobic pathway of endogenous lipid metabolism. We also explore the mechanistic underpinnings of the process where we are able to show that alteration of gene expressions are necessary for hyphal formation at the right population density which is achieved by the proper utilization of an aerobic pathway of endogenous lipid metabolism. In addition, we showed how this mediates biofilm formation itself, and the understanding of these mechanisms can be crucial in designing successful interventional strategies to combat Candida related infections.


Assuntos
Candida albicans/fisiologia , Ácidos Graxos Insaturados/metabolismo , Regulação Fúngica da Expressão Gênica , Hidroxiácidos/metabolismo , Percepção de Quorum , Biofilmes/crescimento & desenvolvimento , Candida albicans/crescimento & desenvolvimento , Candida albicans/metabolismo , Hifas/crescimento & desenvolvimento , Ácido Linoleico/metabolismo
2.
Eur J Obstet Gynecol Reprod Biol ; 152(2): 205-9, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20685028

RESUMO

OBJECTIVE: The selective induction of cyclooxygenase-2 (COX-2) in human cells by Candida albicans was the first report of its role in infectious disease. This led us to question whether recurrent vulvovaginal candidosis in the cancer patient is involved in the formation of malignant tumors of the genital tract. Our speculation coincided with the patients' assessments in our hospital, where few cancer patients had a prior history of Candida infection. We wanted to study the contribution of C. albicans to gynecological cancers. STUDY DESIGN: In the present study, we used the developed vaginal epithelial cells system, having an insertion of HPV 16 viral sequence, as a model system (VK2/E6E7) to investigate the effect of Candida infection on prostaglandin E2 synthesis, which is known to be associated with cancers. We infected VK2/E6E7 cells with wild-type C. albicans and determined its effect on COX-2 and prostaglandin E2 synthesis, and its alteration in dependence on p53, and we analyzed the ubiquitin-proteasome degradation pathways and the involvement of 14-3-3 protein, which is involved in the modulation of the cell cycle. RESULTS: Our work using the cellular model indicates that recurrent Candida infection of the genital tract in patients carrying HPV 16 viral infection blocks the proliferation of host cells, PGE2 synthase expression and thus PGE2 production. CONCLUSION: We found that Candida infection contributes only to cell cycle arrest and does not by itself contribute actively to the development of cancer, although it is associated with patients diagnosed as having cancer of the genital tract induced by HPV 16 virus.


Assuntos
Candida albicans/fisiologia , Ciclo-Oxigenase 2/biossíntese , Dinoprostona/biossíntese , Proteínas 14-3-3/biossíntese , Candidíase Vulvovaginal/fisiopatologia , Ciclo Celular/efeitos dos fármacos , Ciclo Celular/fisiologia , Linhagem Celular , Indução Enzimática , Feminino , Fase G2/efeitos dos fármacos , Neoplasias dos Genitais Femininos/virologia , Células HeLa , Papillomavirus Humano 16/genética , Humanos
3.
FEBS Lett ; 582(2): 279-85, 2008 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-18086569

RESUMO

Non-bullous congenital ichthyosis erythroderma (NCIE) and lamellar ichthyosis (LI) are characterized by mutations in 12R-lipoxygenase (12R-LOX) and/or epidermal lipoxygenase 3 (eLOX3) enzymes. The eLOX3 lacks oxygenase activity, but is capable of forming hepoxilin-type products from arachidonic acid-derived hydroperoxide from 12R-LOX, termed 12R-hydroperoxyeicosa-5,8,10,14-tetraenoic acid (12R-HpETE). Mutations in either of two enzymes lead to NCIE or LI. Moreover, 12R-LOX-deficient mice exhibit severe phenotypic water barrier dysfunctions. Here, we demonstrate that 12R-HpETE can also be transformed to 8R-HXA(3) by hepoxilin A(3) (HXA(3)) synthase (12-lipoxygenase), which exhibits oxygenase activity. We also presented a novel form of ichthyosis in a patient, termed hepoxilin A(3) synthase-linked ichthyosis (HXALI), whose scales expressed high levels of 12R-LOX, but were deficient of HXA(3) synthase.


Assuntos
Araquidonato 12-Lipoxigenase/genética , Eritrodermia Ictiosiforme Congênita/enzimologia , Oxirredutases Intramoleculares/genética , Animais , Araquidonato 12-Lipoxigenase/metabolismo , Sequência de Bases , Cromatografia Líquida de Alta Pressão , Primers do DNA , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Eritrodermia Ictiosiforme Congênita/genética , Oxirredutases Intramoleculares/metabolismo , Lipoxigenase/genética , Masculino , Camundongos , Pessoa de Meia-Idade , Mutação , Proteínas Recombinantes/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa
4.
FEBS J ; 274(14): 3503-3512, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17608719

RESUMO

Hepoxilins are biologically relevant epoxy-hydroxy eicosanoids synthesized through the 12S-lipoxygenase (12S-LOX) pathway of the arachidonic acid (AA) metabolism. The pathway is bifurcated at the level of 12S-hydroperoxy-eicosatetraenoic acid (12S-HpETE), which can either be reduced to 12S-hydro-eicosatetraenoic acid (12S-HETE) or converted to hepoxilins. The present review gives an update on the biochemistry, biology and clinical aspects of hepoxilin-based drug development. The isolation, cloning and characterization of a rat leukocyte-type 12S-LOX from rat insulinoma RINm5F cells revealed a 12S-LOX possessing an intrinsic 8S/R-hydroxy-11,12-epoxyeicosa-5Z,9E,14Z-trienoic acid (HXA(3)) synthase activity. Site-directed mutagenesis studies on rat 12S-LOX showed that the HXA(3) synthase activity was impaired when the positional specificity of AA was altered. Interestingly, amino acid Leu353, and not conventional sequence determinants Met419 and Ile418, was found to be a crucial sequence determinant for AA oxygenation. The regulation of HXA(3) formation is dependent on the cellular overall peroxide tone. Cellular glutathione peroxidases (cGPxs) compete with HXA(3) synthase for 12S-HpETE as substrate either to reduce to 12S-HETE or to convert to HXA(3), respectively. Therefore, RINm5F cells, which are devoid of GPxs, are capable of converting AA or 12S-HpETE to HXA(3) under basal conditions, whereas cells overexpressing cGPx are unable to do so. HXA(3) exhibits a myriad of biological effects, most of which are associated with the stimulation of intracellular calcium or the transport of calcium across the membrane. The activation of HXA(3)-G-protein-coupled receptors explains many of the extracellular effects of HXA(3), including AA- and diacylglycerol (DAG) release in human neutrophils, insulin secretion in rat pancreatic beta-cells or islets, and synaptic actions in the brain. The availability of stable analogs of HXA(3), termed 10-hydroxy-11,12-cyclopropyl-eicosa-5Z,8Z,14Z-trienoic acid derivatives (PBTs), recently made several animal studies possible and explored the role of HXA(3) as a therapeutic in treatment of diseases. Thus, PBT-3 induced apoptosis in K562 tumour cells and inhibited growth of K562 CML solid tumours in nude mice. HXA(3) inhibited bleomycin-evoked lung fibrosis and inflammation in mice and the raised insulin level in the circulation of rats. At low glucose concentrations (0-3 mm), HXA(3) also stimulated insulin secretion in RINm5F cells through the activation of IRE1alpha, an endoplasmic reticulum-resident kinase. The latter regulates the protein folding for insulin biosynthesis. In conclusion, HXA(3)-mediated signaling may be involved in normal physiological functions, and hepoxilin-based drugs may serve as therapeutics in diseases such as type II diabetes and idiopathic lung fibrosis.


Assuntos
Biologia , Ácidos Hidroxieicosatetraenoicos/química , Ácidos Hidroxieicosatetraenoicos/metabolismo , Animais , Araquidonato 12-Lipoxigenase/metabolismo , Fenômenos Bioquímicos , Bioquímica , Humanos , Insulina/metabolismo , Secreção de Insulina , Oxirredutases Intramoleculares/metabolismo
5.
J Mol Med (Berl) ; 85(9): 961-70, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17429597

RESUMO

The cyclooxygenase-2 (COX-2) enzyme is induced upon inflammation and in neoplastic tissues. It produces prostaglandins that stimulate tumor angiogenesis and tumor growth. Therefore, destruction and/or specific inhibition of COX-2 should be an important aspect of future tumor therapy. Recently, clinical application of specific COX-2 inhibitors called coxibs became doubtfully because they produce serious renal and cardiovascular complications under long term application. The exact underlying mechanisms are poorly understood and the different effects of diverse coxibs are not explained. It has been demonstrated before that COX-2 is degraded by the ubiquitin (Ub) proteasome system (UPS). However, how ubiquitination is accomplished and regulated was unclear. An important regulator of the UPS is the COP9 signalosome (CSN), which controls the stability of many proteins. Here we show that the proteasome-dependent degradation of COX-2 in HeLa cell lysate and in HeLa cells was stimulated by curcumin, an inhibitor of CSN-associated kinases. These data suggest a function of the CSN in the degradation of COX-2. In addition, proteolysis of COX-2 was significantly accelerated by parecoxib, but not by celecoxib or rofecoxib. By density gradient centrifugation and immunoprecipitation we demonstrate that COX-2 physically interacts with the CSN. Moreover, COX-2 is associated with large complexes consisting of the CSN, cullin-RING Ub ligases and the 26S proteasome. Pulldown experiments with Flag-COX-2 revealed cullin 1 and cullin 4 as components of the large super-complexes. Cullin 1 and 4 are scaffolding proteins of Ub ligases that presumably ubiquitinate COX-2. Treatment of HeLa cells with parecoxib results in an accelerated degradation of endogenous COX-2 accompanied by an increase of COX-2-Ub conjugates. In HeLa cells parecoxib is converted to the selective COX-2 inhibitor valdecoxib. Addition of valdecoxib also stimulates COX-2 degradation in HeLa cells. We therefore conclude that valdecoxib specifically interacts with COX-2 and induces a conformation accessible for ubiquitination and degradation.


Assuntos
Inibidores de Ciclo-Oxigenase 2/farmacologia , Ciclo-Oxigenase 2/metabolismo , Complexos Multiproteicos/metabolismo , Peptídeo Hidrolases/metabolismo , Complexo de Endopeptidases do Proteassoma/metabolismo , Ubiquitina/metabolismo , Western Blotting , Complexo do Signalossomo COP9 , Proteínas de Ciclo Celular/metabolismo , Cromatografia Líquida de Alta Pressão , Proteínas Culina/metabolismo , Curcumina/farmacologia , Células HeLa , Humanos , Imunoprecipitação , Isoxazóis/farmacologia , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Ubiquitina-Proteína Ligases/metabolismo , Ubiquitinação/efeitos dos fármacos
6.
Biochim Biophys Acta ; 1761(11): 1391-9, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17081801

RESUMO

As saprophytes or disease causing microorganisms, fungi acquire nutrients from dead organic material or living host organisms. Lipids as structural components of cell membranes and storage compartments play an important role as energy-rich food source. In recent years, it also has become clear that lipids have a wide range of bioactive properties including signal transduction and cell to cell communication. Thus, it is not surprising that fungi possess a broad range of hydrolytic enzymes that attack neutral lipids and phospholipids. Especially during infection of a mammalian host, phospholipase A(2) (PLA(2)) enzymes released by fungi could play important roles not only for nutrient acquisition and tissue invasion, but for intricate modulation of the host's immune response. Sequencing of fungal genomes has revealed a wide range of genes encoding PLA(2) activities in fungi. We are just beginning to become aware of the significance these enzymes could have for the fungal cells and their interaction with the host.


Assuntos
Proteínas Fúngicas/metabolismo , Fungos/enzimologia , Lisofosfolipase/metabolismo , Micoses/enzimologia , Fosfolipases A/metabolismo , Transdução de Sinais , Animais , Proteínas Fúngicas/genética , Proteínas Fúngicas/imunologia , Fungos/genética , Fungos/imunologia , Genoma Fúngico/imunologia , Fosfolipases A2 do Grupo IV , Humanos , Lisofosfolipase/genética , Lisofosfolipase/imunologia , Micoses/genética , Micoses/imunologia , Fosfolipases A/genética , Fosfolipases A/imunologia , Fosfolipases A2 , Fosfolipídeos/metabolismo , Transdução de Sinais/genética , Transdução de Sinais/imunologia
7.
Circ Res ; 96(11): 1208-16, 2005 Jun 10.
Artigo em Inglês | MEDLINE | ID: mdl-15905459

RESUMO

During pregnancy, the heart develops a reversible physiological hypertrophic growth in response to mechanical stress and increased cardiac output; however, underlying molecular mechanisms remain unknown. Here, we investigated pregnancy-related changes in heart structure, function, and gene expression of known markers of pathological hypertrophy and cell stretching in mice hearts. In late pregnancy, hearts show eccentric hypertrophy, as expected for a response to volume overload, with normal left ventricular diastolic function and a moderate reduction in systolic function. Pregnancy-related physiological heart hypertrophy does not induce expression changes of known markers of pathological hypertrophy like: alpha- and beta-myosin heavy chain, atrial natriuretic factor, phospholamban, and sarcoplasmic reticulum Ca2+-ATPase. Instead, it induces the remodeling of Kv4.3 channel and increased c-Src tyrosine kinase activity, a stretch-responsive kinase. Cardiac Kv4.3 channel gene expression was downregulated by approximately 3- to 5-fold, both at the mRNA and protein levels, and was paralleled by a reduction in transient outward K+ currents, a longer action potential and by prolongation of the QT interval. Downregulation of cardiac Kv4.3 transcripts was mimicked by estrogen treatment in ovariectomized mice, and was prevented by the estrogen receptor antagonist ICI 182,780. c-Src activity increased by approximately 2-fold in late pregnancy and after estrogen treatment. We propose that, in addition to mechanical stress, the rise of estrogen toward the end of pregnancy contributes to pregnancy-related heart hypertrophy by increased c-Src activity and that the rise of estrogen is one factor that down regulates cardiac Kv4.3 gene expression providing a molecular correlate for a longer QT interval in pregnancy.


Assuntos
Cardiomegalia/fisiopatologia , Complicações Cardiovasculares na Gravidez/fisiopatologia , Potenciais de Ação , Animais , Proteína Tirosina Quinase CSK , Cardiomegalia/etiologia , Cardiomegalia/patologia , Ecocardiografia , Eletrocardiografia , Estradiol/análogos & derivados , Estradiol/farmacologia , Estrogênios/farmacologia , Feminino , Fulvestranto , Camundongos , Camundongos Endogâmicos C57BL , Miocárdio/patologia , Canais de Potássio/fisiologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana/análise , Canais de Potássio de Abertura Dependente da Tensão da Membrana/genética , Gravidez , Complicações Cardiovasculares na Gravidez/etiologia , Complicações Cardiovasculares na Gravidez/patologia , Proteínas Tirosina Quinases/metabolismo , Canais de Potássio Shal , Função Ventricular Esquerda , Quinases da Família src
8.
J Immunol ; 171(6): 3047-55, 2003 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-12960330

RESUMO

Candidiasis, in its mucocutaneous form as well as in an invasive form, is frequently associated with high morbidity. PGE(2), which is generated by enzymatic activity of cyclooxygenases (COXs) 1 and 2, has been shown to trigger morphogenesis in Candida albicans. In the present study, we investigated whether C. albicans altered COX-2 expression in HeLa cells. RT-PCR and Western blot analyses revealed a time-dependent biphasic behavior of COX-2 mRNA expression and COX-2 protein level. COX-1 protein remained unaffected. Neutralization with Abs against Toll-like receptors (TLR) 2 and 4 inhibited the Candida-induced production of PGE(2), suggesting a vital role for TLRs in the recognition and signaling in mammalian cells upon infection with C. albicans. Transient transfections with COX-2 promoter-luciferase construct and various inhibitors of mitogen-activated protein kinases (MAPK), such as protein kinase C (PKC) inhibitor GF203190X, p38(MAPK) inhibitor SB203109, and extracellular-regulated kinases 1 and 2 inhibitor PD98509 showed that C. albicans up-regulates selectively COX-2, but not COX-1, through p38(MAPK) and PKC pathways. No involvement of other stress kinases, e.g., c-Jun NH(2)-terminal kinase and extracellular-regulated kinases 1 and 2, was observed. Transient transfection of NF-kappaB promoter construct and dominant negative plasmid of IkappaBbeta kinase showed that COX-2 transcription is mediated through p38(MAPK) and NF-kappaB pathways. That NF-kappaB up-regulates p38(MAPK) is novel and is in contradiction to earlier reports in which NF-kappaB was shown to inhibit p38(MAPK). In conclusion, multiple converging signaling pathways, involving TLRs followed by PKC, p38(MAPK), and/or NF-kappaB, are triggered by C. albicans in activation of COX-2 gene.


Assuntos
Candida albicans/fisiologia , Isoenzimas/genética , Isoenzimas/metabolismo , Glicoproteínas de Membrana/fisiologia , Proteínas Quinases Ativadas por Mitógeno/fisiologia , NF-kappa B/fisiologia , Prostaglandina-Endoperóxido Sintases/genética , Prostaglandina-Endoperóxido Sintases/metabolismo , Receptores de Superfície Celular/fisiologia , Ativação Transcricional/fisiologia , Candida albicans/efeitos dos fármacos , Ciclo-Oxigenase 2 , Inibidores de Ciclo-Oxigenase 2 , Inibidores de Ciclo-Oxigenase/farmacologia , Dinoprostona/biossíntese , Ativação Enzimática/efeitos dos fármacos , Ativação Enzimática/fisiologia , Inibidores Enzimáticos/farmacologia , Células HeLa , Humanos , Isoenzimas/antagonistas & inibidores , Isoenzimas/biossíntese , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/fisiologia , Proteínas de Membrana , Proteínas Quinases Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Estresse Oxidativo/fisiologia , Prostaglandina-Endoperóxido Sintases/biossíntese , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/fisiologia , Espécies Reativas de Oxigênio/antagonistas & inibidores , Receptor 2 Toll-Like , Receptores Toll-Like , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/fisiologia , Proteínas Quinases p38 Ativadas por Mitógeno
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...